Research / HIND / Fundamental state Inspectable configuration
State dimensions Filing 0001558370-23-006079 General Corporate
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.17% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-194.86% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-17.35% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
32.13% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
60.52% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-412.38% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
22.57% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
18.57% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 19 states Self-history eligible
Dec 31, 2021 0/6 normalized Level 3 Mar 31, 2022 0/7 normalized Level 3 Jun 30, 2022 0/7 normalized Level 3 Sep 30, 2022 0/7 normalized Level 3 Dec 31, 2022 0/8 normalized Level 3 Mar 31, 2023 0/8 normalized Level 3 Jun 30, 2023 0/8 normalized Level 3 Sep 30, 2023 0/8 normalized Level 3 Dec 31, 2023 6/8 normalized Level 3 Mar 31, 2024 6/7 normalized Level 3 Jun 30, 2024 6/7 normalized Level 3 Sep 30, 2024 6/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 6/6 normalized Level 3 Dec 31, 2025 6/6 normalized Level 3 Mar 31, 2026 6/6 normalized Level 3 Jun 30, 2026 6/6 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 1.18%
Current 1.17%
Delta -0.01% Cash Generation Decreased
Previous -188.42%
Current -194.86%
Delta -6.44% Inventory Pressure Decreased
Previous 149.07%
Current 32.13%
Delta -116.94% Margin Decreased
Previous 75.09%
Current 60.52%
Delta -14.57% Profitability Increased
Previous -426.23%
Current -412.38%
Delta 13.86% R And D Intensity Increased
Previous 21.02%
Current 22.57%
Delta 1.56% Sbc Intensity Increased
Previous 13.87%
Current 18.57%
Delta 4.70% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.